HCP Alerts
Voyager HCP Alerts use pathology and genomic testing results to identify the providers whose patients may be eligible for your therapy, and flag them the same day, when they are ready to hear a branded message. Alerts are keyed to the biomarkers and ICD-10 codes your brand is built around.
60K
HER2 IHC across tumors, a year
20K
ER/PR in breast, a year
30K
Heme and solid tumor liquid biopsies, a year
20K
Comprehensive genomic solid tumor profiles, a year
Tell us the brand, the biomarkers or ICD-10 codes, and the geography you care about. We will show you the providers and triggers Voyager would hand your field team.
The target list we build on the call is yours to keep, whether or not you go further.
Quarterly reports tell you what already happened. Voyager watches the resolved market and raises a trigger when something changes, so the field hears about it in time to act.
01
Set alerts against the biomarkers that matter to your brand — ER, PR, HER2, PD-L1 and genomic markers across single-analyte testing and next-generation sequencing. A first order, a shift in testing pattern, or volume moving to another site raises a trigger tied to that marker.
02
Alerts can key off diagnosis codes as well as markers, so you can watch the indications your therapy is built for rather than a whole specialty.
03
The same view surfaces where testing is not happening. Gaps can be identified and closed, so precision medicine reaches the patients whose care depends on it.
04
Each alert names both the ordering and the treating physician behind the cohort, along with the facility where it surfaced.
Alerts run on data sourced from the Hyperdrive Lab Data Network. Partner laboratories send clinical, anatomic pathology and laboratory genomic data directly, and Nexus resolves it to organizations and providers — not a licensed panel every competitor can buy. More about the Lab Network
Laboratory testing and results data is aggregated and summarized to the individual healthcare provider before it reaches Voyager, so every alert describes provider-level testing behavior. Historical Medicare Part B and Part D claims add a longer record of procedures and prescribing.
Alerts are set against specific biomarkers or ICD-10 codes. A first order, a confirmed result, a shift in testing pattern, or volume moving to another site raises a trigger tied to that marker or code.
Common biomarkers including ER, PR, HER2 and PD-L1, plus genomic markers across both single-analyte testing and next-generation sequencing.
Yes. The same view that surfaces ordering behavior surfaces its absence, so gaps in community testing can be identified and closed.
The individual healthcare provider. Laboratory testing and results data is de-identified, then aggregated and summarized to the provider before it reaches Voyager, so alerts report provider-level testing behavior rather than anything below it.
Partner laboratories in the Hyperdrive Lab Data Network send clinical, anatomic pathology and laboratory genomic data directly. Nexus, our data platform, resolves it to organizations and providers before it reaches Voyager.